Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 290

1.

Prevalence of TTR variants detected by whole-exome sequencing in hypertrophic cardiomyopathy.

Lopes LR, Futema M, Akhtar MM, Lorenzini M, Pittman A, Syrris P, Elliott PM.

Amyloid. 2019 Sep 25:1-5. doi: 10.1080/13506129.2019.1665996. [Epub ahead of print]

PMID:
31554435
2.

Response to Gurevich and colleagues: The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: a systematic literature review by a European panel of experts.

Germain DP, Falissard B, Hilz MJ, Spada M, Wanner C, Elliott PM.

Mol Genet Metab Rep. 2019 Jul 22;20:100493. doi: 10.1016/j.ymgmr.2019.100493. eCollection 2019 Sep. No abstract available.

3.

Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids).

Norrish G, Ding T, Field E, Ziólkowska L, Olivotto I, Limongelli G, Anastasakis A, Weintraub R, Biagini E, Ragni L, Prendiville T, Duignan S, McLeod K, Ilina M, Fernández A, Bökenkamp R, Baban A, Kubuš P, Daubeney PEF, Sarquella-Brugada G, Cesar S, Marrone C, Bhole V, Medrano C, Uzun O, Brown E, Gran F, Castro FJ, Stuart G, Vignati G, Barriales-Villa R, Guereta LG, Adwani S, Linter K, Bharucha T, Garcia-Pavia P, Rasmussen TB, Calcagnino MM, Jones CB, De Wilde H, Toru-Kubo J, Felice T, Mogensen J, Mathur S, Reinhardt Z, O'Mahony C, Elliott PM, Omar RZ, Kaski JP.

JAMA Cardiol. 2019 Aug 14. doi: 10.1001/jamacardio.2019.2861. [Epub ahead of print]

PMID:
31411652
4.

Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study.

Augusto JB, Eiros R, Nakou E, Moura-Ferreira S, Treibel TA, Captur G, Akhtar MA, Protonotarios A, Gossios TD, Savvatis K, Syrris P, Mohiddin S, Moon JC, Elliott PM, Lopes LR.

Eur Heart J Cardiovasc Imaging. 2019 Jul 16. pii: jez188. doi: 10.1093/ehjci/jez188. [Epub ahead of print]

PMID:
31317183
5.

Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy.

Limongelli G, Monda E, Tramonte S, Gragnano F, Masarone D, Frisso G, Esposito A, Gravino R, Ammendola E, Salerno G, Rubino M, Caiazza M, Russo M, Calabrò P, Elliott PM, Pacileo G.

Int J Cardiol. 2019 Jul 4. pii: S0167-5273(19)30883-6. doi: 10.1016/j.ijcard.2019.06.073. [Epub ahead of print]

PMID:
31303393
6.

Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice.

Witteles RM, Bokhari S, Damy T, Elliott PM, Falk RH, Fine NM, Gospodinova M, Obici L, Rapezzi C, Garcia-Pavia P.

JACC Heart Fail. 2019 Aug;7(8):709-716. doi: 10.1016/j.jchf.2019.04.010. Epub 2019 Jul 10. Review.

7.

Identification of a Multiplex Biomarker Panel for Hypertrophic Cardiomyopathy using Quantitative Proteomics and Machine Learning.

Captur G, Heywood WE, Coats C, Rosmini S, Patel V, Lopes LR, Collis R, Patel N, Syrris P, Bassett P, O'Brien B, Moon J, Elliott PM, Mills K.

Mol Cell Proteomics. 2019 Jun 26. pii: mcp.RA119.001586. doi: 10.1074/mcp.RA119.001586. [Epub ahead of print]

8.

Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report.

Elliott PM, Anastasakis A, Asimaki A, Basso C, Bauce B, Brooke MA, Calkins H, Corrado D, Duru F, Green KJ, Judge DP, Kelsell D, Lambiase PD, McKenna WJ, Pilichou K, Protonotarios A, Saffitz JE, Syrris P, Tandri H, Te Riele A, Thiene G, Tsatsopoulou A, van Tintelen JP.

Eur J Heart Fail. 2019 Aug;21(8):955-964. doi: 10.1002/ejhf.1534. Epub 2019 Jun 18.

9.

Why systematic literature reviews in Fabry disease should include all published evidence.

Elliott PM, Germain DP, Hilz MJ, Spada M, Wanner C, Falissard B.

Eur J Med Genet. 2019 Oct;62(10):103702. doi: 10.1016/j.ejmg.2019.103702. Epub 2019 Jun 10. Review.

10.

Hypertrophic Cardiomyopathy-Need for Gene-Specific Treatment?-Reply.

Coats CJ, Frenneaux MP, Elliott PM.

JAMA Cardiol. 2019 Jun 12. doi: 10.1001/jamacardio.2019.1766. [Epub ahead of print] No abstract available.

PMID:
31188395
11.

Left ventricular non-compaction: have we reached the limits of conventional imaging?

Protonotarios A, Elliott PM.

Eur Heart J. 2019 Jun 4. pii: ehz352. doi: 10.1093/eurheartj/ehz352. [Epub ahead of print] No abstract available.

PMID:
31162535
12.

Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree Relatives.

Norrish G, Jager J, Field E, Quinn E, Fell H, Lord E, Cicerchia MN, Ochoa JP, Cervi E, Elliott PM, Kaski JP.

Circulation. 2019 Jul 16;140(3):184-192. doi: 10.1161/CIRCULATIONAHA.118.038846. Epub 2019 Apr 22.

13.

Reply: Revisiting Genome Sequencing Data in Light of Novel Disease Gene Associations.

Ochoa JP, Elliott PM, Gimeno JR, Monserrat L.

J Am Coll Cardiol. 2019 Mar 26;73(11):1366-1367. doi: 10.1016/j.jacc.2019.01.022. No abstract available.

PMID:
30898216
14.

Arrhythmogenic cardiomyopathies (ACs): diagnosis, risk stratification and management.

Protonotarios A, Elliott PM.

Heart. 2019 Jul;105(14):1117-1128. doi: 10.1136/heartjnl-2017-311160. Epub 2019 Feb 21. No abstract available.

PMID:
30792239
15.

The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts.

Germain DP, Elliott PM, Falissard B, Fomin VV, Hilz MJ, Jovanovic A, Kantola I, Linhart A, Mignani R, Namdar M, Nowak A, Oliveira JP, Pieroni M, Viana-Baptista M, Wanner C, Spada M.

Mol Genet Metab Rep. 2019 Feb 6;19:100454. doi: 10.1016/j.ymgmr.2019.100454. eCollection 2019 Jun. Review.

16.

Tafamidis for the treatment of transthyretin amyloidosis.

Lorenzini M, Elliott PM.

Future Cardiol. 2019 Mar;15(2):53-61. doi: 10.2217/fca-2018-0078. Epub 2019 Feb 15. Review.

PMID:
30767672
17.

Effect of Trimetazidine Dihydrochloride Therapy on Exercise Capacity in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A Randomized Clinical Trial.

Coats CJ, Pavlou M, Watkinson OT, Protonotarios A, Moss L, Hyland R, Rantell K, Pantazis AA, Tome M, McKenna WJ, Frenneaux MP, Omar R, Elliott PM.

JAMA Cardiol. 2019 Mar 1;4(3):230-235. doi: 10.1001/jamacardio.2018.4847.

PMID:
30725091
18.

Proteomic Analysis of the Myocardium in Hypertrophic Obstructive Cardiomyopathy.

Coats CJ, Heywood WE, Virasami A, Ashrafi N, Syrris P, Dos Remedios C, Treibel TA, Moon JC, Lopes LR, McGregor CGA, Ashworth M, Sebire NJ, McKenna WJ, Mills K, Elliott PM.

Circ Genom Precis Med. 2018 Dec;11(12):e001974. doi: 10.1161/CIRCGEN.117.001974.

PMID:
30562113
19.

Cardiac manifestations of McArdle disease.

Jones DM, Lopes L, Quinlivan R, Elliott PM, Khanji MY.

Eur Heart J. 2019 Jan 21;40(4):397-398. doi: 10.1093/eurheartj/ehy783. No abstract available.

PMID:
30534954
20.

Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy.

Ochoa JP, Sabater-Molina M, García-Pinilla JM, Mogensen J, Restrepo-Córdoba A, Palomino-Doza J, Villacorta E, Martinez-Moreno M, Ramos-Maqueda J, Zorio E, Peña-Peña ML, García-Granja PE, Rodríguez-Palomares JF, Cárdenas-Reyes IJ, de la Torre-Carpente MM, Bautista-Pavés A, Akhtar MM, Cicerchia MN, Bilbao-Quesada R, Mogollón-Jimenez MV, Salazar-Mendiguchía J, Mesa Latorre JM, Arnaez B, Olavarri-Miguel I, Fuentes-Cañamero ME, Lamounier A Jr, Pérez Ruiz JM, Climent-Payá V, Pérez-Sanchez I, Trujillo-Quintero JP, Lopes LR, Repáraz-Andrade A, Marín-Iglesias R, Rodriguez-Vilela A, Sandín-Fuentes M, Garrote JA, Cortel-Fuster A, Lopez-Garrido M, Fontalba-Romero A, Ripoll-Vera T, Llano-Rivas I, Fernandez-Fernandez X, Isidoro-García M, Garcia-Giustiniani D, Barriales-Villa R, Ortiz-Genga M, García-Pavía P, Elliott PM, Gimeno JR, Monserrat L.

J Am Coll Cardiol. 2018 Nov 13;72(20):2457-2467. doi: 10.1016/j.jacc.2018.10.001.

21.

The effect of enzyme replacement therapy on clinical outcomes in female patients with Fabry disease - A systematic literature review by a European panel of experts.

Germain DP, Arad M, Burlina A, Elliott PM, Falissard B, Feldt-Rasmussen U, Hilz MJ, Hughes DA, Ortiz A, Wanner C, Weidemann F, Spada M.

Mol Genet Metab. 2019 Mar;126(3):224-235. doi: 10.1016/j.ymgme.2018.09.007. Epub 2018 Sep 27. Review.

22.

Loss-of-function desmoplakin I and II mutations underlie dominant arrhythmogenic cardiomyopathy with a hair and skin phenotype.

Maruthappu T, Posafalvi A, Castelletti S, Delaney PJ, Syrris P, O'Toole EA, Green KJ, Elliott PM, Lambiase PD, Tinker A, McKenna WJ, Kelsell DP.

Br J Dermatol. 2019 May;180(5):1114-1122. doi: 10.1111/bjd.17388. Epub 2019 Jan 2.

PMID:
30382575
23.

Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: a systematic review and meta-analysis.

O'Mahony C, Akhtar MM, Anastasiou Z, Guttmann OP, Vriesendorp PA, Michels M, Magrì D, Autore C, Fernández A, Ochoa JP, Leong KMW, Varnava AM, Monserrat L, Anastasakis A, Garcia-Pavia P, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, Omar RZ, Elliott PM.

Heart. 2019 Apr;105(8):623-631. doi: 10.1136/heartjnl-2018-313700. Epub 2018 Oct 26.

PMID:
30366935
24.

No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathy.

Hoorntje ET, Posafalvi A, Syrris P, van der Velde KJ, Bolling MC, Protonotarios A, Boven LG, Amat-Codina N, Groeneweg JA, Wilde AA, Sobreira N, Calkins H, Hauer RNW, Jonkman MF, McKenna WJ, Elliott PM, Sinke RJ, van den Berg MP, Chelko SP, James CA, van Tintelen JP, Judge DP, Jongbloed JDH.

PLoS One. 2018 Aug 30;13(8):e0203078. doi: 10.1371/journal.pone.0203078. eCollection 2018.

25.

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.

Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C; ATTR-ACT Study Investigators.

N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27.

26.

[2018 ESC Guidelines for the diagnosis and management of syncope].

Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli A, Fedorowski A, Furlan R, Kenny RA, Martiın A, Probst V, Reed MJ, Rice CP, Sutton R, Ungar A, van Dijk JG.

Kardiol Pol. 2018;76(8):1119-1198. doi: 10.5603/KP.2018.0161. Polish. No abstract available.

27.

Rare Diseases in Cardiovascular Medicine II.

Majid Akhtar M, Elliott PM.

Eur Heart J. 2017 Jun 1;38(21):1629-1631. doi: 10.1093/eurheartj/ehx242. No abstract available.

PMID:
30052875
28.

European expert consensus statement on therapeutic goals in Fabry disease.

Wanner C, Arad M, Baron R, Burlina A, Elliott PM, Feldt-Rasmussen U, Fomin VV, Germain DP, Hughes DA, Jovanovic A, Kantola I, Linhart A, Mignani R, Monserrat L, Namdar M, Nowak A, Oliveira JP, Ortiz A, Pieroni M, Spada M, Tylki-Szymańska A, Tøndel C, Viana-Baptista M, Weidemann F, Hilz MJ.

Mol Genet Metab. 2018 Jul;124(3):189-203. doi: 10.1016/j.ymgme.2018.06.004. Epub 2018 Jun 12. Review.

PMID:
30017653
29.

Arrhythmogenic right ventricular cardiomyopathy as a hidden cause of paediatric myocarditis presentation.

Protonotarios A, Elliott PM.

Int J Cardiol. 2018 Nov 15;271:113-114. doi: 10.1016/j.ijcard.2018.06.117. Epub 2018 Jul 2. No abstract available.

PMID:
29983250
30.

Diagnostic Clues for the Diagnosis of Nonsarcomeric Hypertrophic Cardiomyopathy (Phenocopies): Amyloidosis, Fabry Disease, and Mitochondrial Disease.

Limongelli G, Masarone D, Verrengia M, Gravino R, Salerno G, Castelletti S, Rubino M, Marrazzo T, Pisani A, Cecchi F, Elliott PM, Pacileo G.

J Cardiovasc Echogr. 2018 Apr-Jun;28(2):120-123. doi: 10.4103/jcecho.jcecho_2_18.

31.

Anderson-Fabry disease in heart failure.

Akhtar MM, Elliott PM.

Biophys Rev. 2018 Aug;10(4):1107-1119. doi: 10.1007/s12551-018-0432-5. Epub 2018 Jun 16. Review.

32.

Outcomes following the surgical management of left ventricular outflow tract obstruction; A systematic review and meta-analysis.

Collis RA, Rahman MS, Watkinson O, Guttmann OP, O'Mahony C, Elliott PM.

Int J Cardiol. 2018 Aug 15;265:62-70. doi: 10.1016/j.ijcard.2018.01.130.

PMID:
29885701
33.

Assessment of a conduction-repolarisation metric to predict Arrhythmogenesis in right ventricular disorders.

Martin CA, Orini M, Srinivasan NT, Bhar-Amato J, Honarbakhsh S, Chow AW, Lowe MD, Ben-Simon R, Elliott PM, Taggart P, Lambiase PD.

Int J Cardiol. 2018 Nov 15;271:75-80. doi: 10.1016/j.ijcard.2018.05.063. Epub 2018 May 20.

34.

The effect of enzyme replacement therapy on clinical outcomes in paediatric patients with Fabry disease - A systematic literature review by a European panel of experts.

Spada M, Baron R, Elliott PM, Falissard B, Hilz MJ, Monserrat L, Tøndel C, Tylki-Szymańska A, Wanner C, Germain DP.

Mol Genet Metab. 2019 Mar;126(3):212-223. doi: 10.1016/j.ymgme.2018.04.007. Epub 2018 Apr 26. Review.

35.

Therapeutic goals in Fabry disease: Recommendations of a European expert panel, based on current clinical evidence with enzyme replacement therapy.

Wanner C, Germain DP, Hilz MJ, Spada M, Falissard B, Elliott PM.

Mol Genet Metab. 2019 Mar;126(3):210-211. doi: 10.1016/j.ymgme.2018.04.004. Epub 2018 Apr 11. No abstract available.

PMID:
29724657
36.

2018 ESC Guidelines for the diagnosis and management of syncope.

Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli A, Fedorowski A, Furlan R, Kenny RA, Martín A, Probst V, Reed MJ, Rice CP, Sutton R, Ungar A, van Dijk JG; ESC Scientific Document Group .

Eur Heart J. 2018 Jun 1;39(21):1883-1948. doi: 10.1093/eurheartj/ehy037. No abstract available.

37.

Practical Instructions for the 2018 ESC Guidelines for the diagnosis and management of syncope.

Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli A, Fedorowski A, Furlan R, Kenny RA, Martín A, Probst V, Reed MJ, Rice CP, Sutton R, Ungar A, van Dijk JG; ESC Scientific Document Group.

Eur Heart J. 2018 Jun 1;39(21):e43-e80. doi: 10.1093/eurheartj/ehy071. No abstract available.

PMID:
29562291
38.

On the Road from Gene to Therapy in Inherited Cardiomyopathies.

Limongelli G, Bossone E, Elliott PM, Day SM.

Heart Fail Clin. 2018 Apr;14(2):xi-xv. doi: 10.1016/j.hfc.2018.01.003. No abstract available.

PMID:
29525651
39.

Epidemiology and Clinical Aspects of Genetic Cardiomyopathies.

Masarone D, Kaski JP, Pacileo G, Elliott PM, Bossone E, Day SM, Limongelli G.

Heart Fail Clin. 2018 Apr;14(2):119-128. doi: 10.1016/j.hfc.2017.12.007. Review.

PMID:
29525641
40.

Transforming care for rare and inherited cardiovascular diseases through education and training.

Elliott PM, Camici P.

Int J Cardiol. 2018 Apr 15;257:342-343. doi: 10.1016/j.ijcard.2018.01.035. No abstract available.

PMID:
29506728
41.

Multifocal ectopic Purkinje-related premature contractions: Sorting the wheat from the chaff.

Elliott PM.

Int J Cardiol. 2018 Apr 15;257:218-219. doi: 10.1016/j.ijcard.2018.01.024. No abstract available.

PMID:
29506695
42.

Improving Interpretation of Cardiac Phenotypes and Enhancing Discovery With Expanded Knowledge in the Gene Ontology.

Lovering RC, Roncaglia P, Howe DG, Laulederkind SJF, Khodiyar VK, Berardini TZ, Tweedie S, Foulger RE, Osumi-Sutherland D, Campbell NH, Huntley RP, Talmud PJ, Blake JA, Breckenridge R, Riley PR, Lambiase PD, Elliott PM, Clapp L, Tinker A, Hill DP.

Circ Genom Precis Med. 2018 Feb;11(2):e001813. doi: 10.1161/CIRCGEN.117.001813.

43.

Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study.

Arends M, Biegstraaten M, Wanner C, Sirrs S, Mehta A, Elliott PM, Oder D, Watkinson OT, Bichet DG, Khan A, Iwanochko M, Vaz FM, van Kuilenburg ABP, West ML, Hughes DA, Hollak CEM.

J Med Genet. 2018 May;55(5):351-358. doi: 10.1136/jmedgenet-2017-104863. Epub 2018 Feb 7.

44.

The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies.

Charron P, Elliott PM, Gimeno JR, Caforio ALP, Kaski JP, Tavazzi L, Tendera M, Maupain C, Laroche C, Rubis P, Jurcut R, Calò L, Heliö TM, Sinagra G, Zdravkovic M, Kavoliuniene A, Felix SB, Grzybowski J, Losi MA, Asselbergs FW, García-Pinilla JM, Salazar-Mendiguchia J, Mizia-Stec K, Maggioni AP; EORP Cardiomyopathy Registry Investigators.

Eur Heart J. 2018 May 21;39(20):1784-1793. doi: 10.1093/eurheartj/ehx819.

PMID:
29378019
45.

Evolving Story of Clinical Trials in Hypertrophic Cardiomyopathy.

Elliott PM.

Circ Heart Fail. 2018 Jan;11(1):e004572. doi: 10.1161/CIRCHEARTFAILURE.117.004572. No abstract available.

PMID:
29321133
46.

Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.

Wicks EC, Menezes LJ, Barnes A, Mohiddin SA, Sekhri N, Porter JC, Booth HL, Garrett E, Patel RS, Pavlou M, Groves AM, Elliott PM.

Eur Heart J Cardiovasc Imaging. 2018 Jul 1;19(7):757-767. doi: 10.1093/ehjci/jex340.

PMID:
29319785
47.

Individualized surgical strategies for left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.

Collis R, Tsang V, Pantazis A, Tome-Esteban M, Elliott PM, McGregor CGA.

Eur J Cardiothorac Surg. 2018 Jun 1;53(6):1237-1243. doi: 10.1093/ejcts/ezx458.

PMID:
29293974
48.

Evolving concepts in dilated cardiomyopathy.

Merlo M, Cannatà A, Gobbo M, Stolfo D, Elliott PM, Sinagra G.

Eur J Heart Fail. 2018 Feb;20(2):228-239. doi: 10.1002/ejhf.1103. Epub 2017 Dec 22. Review.

49.

International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM).

O'Mahony C, Jichi F, Ommen SR, Christiaans I, Arbustini E, Garcia-Pavia P, Cecchi F, Olivotto I, Kitaoka H, Gotsman I, Carr-White G, Mogensen J, Antoniades L, Mohiddin SA, Maurer MS, Tang HC, Geske JB, Siontis KC, Mahmoud KD, Vermeer A, Wilde A, Favalli V, Guttmann OP, Gallego-Delgado M, Dominguez F, Tanini I, Kubo T, Keren A, Bueser T, Waters S, Issa IF, Malcolmson J, Burns T, Sekhri N, Hoeger CW, Omar RZ, Elliott PM.

Circulation. 2018 Mar 6;137(10):1015-1023. doi: 10.1161/CIRCULATIONAHA.117.030437. Epub 2017 Nov 30.

PMID:
29191938
50.

Lamin and the heart.

Captur G, Arbustini E, Bonne G, Syrris P, Mills K, Wahbi K, Mohiddin SA, McKenna WJ, Pettit S, Ho CY, Muchir A, Gissen P, Elliott PM, Moon JC.

Heart. 2018 Mar;104(6):468-479. doi: 10.1136/heartjnl-2017-312338. Epub 2017 Nov 25. Review.

PMID:
29175975

Supplemental Content

Loading ...
Support Center